New

Cell and Gene Therapy Market

2021

Cell and Gene Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Cell Therapy, Gene Therapy); Application (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others); End- Users (Hospital, Clinics, Others) and Geography

| Report Code: TIPRE00020854 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Cell and Gene Therapy Market 2028 By Type, Application, End- Users and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by introducing cells into a patient's body or by using cells to carry a therapy through the body. Cells are cultured or altered outside the patient's body before being injected into the patient.

MARKET DYNAMICS

The increasing incidences of several chronic diseases, cardiovascular and neurological diseases across the globe is supposed to drive the development of the cell and gene therapy market. The rising number of clinical trials and increase in funding's and investments in this market are expected to surge the market. Furthermore, the improved healthcare facilities in developed countries are also going to increase the market growth, whereas, lack of reliable vector production, complex manufacturing and distribution layout and excessive costs of treatment method may serve as market constraints for the cell and gene therapy market.

MARKET SCOPE

The "Cell and gene therapy market analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell and gene therapy market with detailed market segmentation by type, application and end users. The cell and gene therapy market are expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cell and gene therapy market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The cell and gene therapy market are segmented on the basis of type, application and end users. On the basis of type, the market is segmented into cell therapy and gene therapy. On the basis of application, the market is segmented as oncology, dermatology, musculoskeletal, genetic disorders and others. On the basis of end users, the market is segmented as hospital and clinics and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell and gene therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell and gene therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cell and gene therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the cell and gene therapy market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the cell and gene therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cell and gene therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for cell and gene therapy in the global market. Below mentioned is the list of few companies engaged in the cell and gene therapy market.

The report also includes the profiles of key players in cell and gene therapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Gilead Sciences.
  •  Bristol-Myers Squibb.
  •  Novartis AG.
  •  Spark Therapeutics.
  •  Amgen.
  •  Merck.
  •  Biogen.
  •  Pfizer.
  •  Dendreon.
  •  Vericel.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell And Gene Therapy Market - By Type
1.3.2 Cell And Gene Therapy Market - By Application
1.3.3 Cell And Gene Therapy Market - By End- Users
1.3.4 Cell And Gene Therapy Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CELL AND GENE THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. CELL AND GENE THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CELL AND GENE THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL AND GENE THERAPY - GLOBAL MARKET OVERVIEW
6.2. CELL AND GENE THERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. CELL AND GENE THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CELL THERAPY
7.3.1. Overview
7.3.2. Cell Therapy Market Forecast and Analysis
7.4. GENE THERAPY
7.4.1. Overview
7.4.2. Gene Therapy Market Forecast and Analysis
8. CELL AND GENE THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. DERMATOLOGY
8.4.1. Overview
8.4.2. Dermatology Market Forecast and Analysis
8.5. MUSCULOSKELETAL
8.5.1. Overview
8.5.2. Musculoskeletal Market Forecast and Analysis
8.6. GENETIC DISORDERS
8.6.1. Overview
8.6.2. Genetic Disorders Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. CELL AND GENE THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - END- USERS
9.1. OVERVIEW
9.2. END- USERS MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. CELL AND GENE THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cell And Gene Therapy Market Overview
10.1.2 North America Cell And Gene Therapy Market Forecasts and Analysis
10.1.3 North America Cell And Gene Therapy Market Forecasts and Analysis - By Type
10.1.4 North America Cell And Gene Therapy Market Forecasts and Analysis - By Application
10.1.5 North America Cell And Gene Therapy Market Forecasts and Analysis - By End- Users
10.1.6 North America Cell And Gene Therapy Market Forecasts and Analysis - By Countries
10.1.6.1 Canada Cell And Gene Therapy Market
10.1.6.1.1 Canada Cell And Gene Therapy Market by Type
10.1.6.1.2 Canada Cell And Gene Therapy Market by Application
10.1.6.1.3 Canada Cell And Gene Therapy Market by End- Users
10.1.6.2 Mexico Cell And Gene Therapy Market
10.1.6.2.1 Mexico Cell And Gene Therapy Market by Type
10.1.6.2.2 Mexico Cell And Gene Therapy Market by Application
10.1.6.2.3 Mexico Cell And Gene Therapy Market by End- Users
10.1.6.3 US Cell And Gene Therapy Market
10.1.6.3.1 US Cell And Gene Therapy Market by Type
10.1.6.3.2 US Cell And Gene Therapy Market by Application
10.1.6.3.3 US Cell And Gene Therapy Market by End- Users
10.2. EUROPE
10.2.1 Europe Cell And Gene Therapy Market Overview
10.2.2 Europe Cell And Gene Therapy Market Forecasts and Analysis
10.2.3 Europe Cell And Gene Therapy Market Forecasts and Analysis - By Type
10.2.4 Europe Cell And Gene Therapy Market Forecasts and Analysis - By Application
10.2.5 Europe Cell And Gene Therapy Market Forecasts and Analysis - By End- Users
10.2.6 Europe Cell And Gene Therapy Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cell And Gene Therapy Market
10.2.6.1.1 Germany Cell And Gene Therapy Market by Type
10.2.6.1.2 Germany Cell And Gene Therapy Market by Application
10.2.6.1.3 Germany Cell And Gene Therapy Market by End- Users
10.2.6.2 France Cell And Gene Therapy Market
10.2.6.2.1 France Cell And Gene Therapy Market by Type
10.2.6.2.2 France Cell And Gene Therapy Market by Application
10.2.6.2.3 France Cell And Gene Therapy Market by End- Users
10.2.6.3 Italy Cell And Gene Therapy Market
10.2.6.3.1 Italy Cell And Gene Therapy Market by Type
10.2.6.3.2 Italy Cell And Gene Therapy Market by Application
10.2.6.3.3 Italy Cell And Gene Therapy Market by End- Users
10.2.6.4 Spain Cell And Gene Therapy Market
10.2.6.4.1 Spain Cell And Gene Therapy Market by Type
10.2.6.4.2 Spain Cell And Gene Therapy Market by Application
10.2.6.4.3 Spain Cell And Gene Therapy Market by End- Users
10.2.6.5 United Kingdom Cell And Gene Therapy Market
10.2.6.5.1 United Kingdom Cell And Gene Therapy Market by Type
10.2.6.5.2 United Kingdom Cell And Gene Therapy Market by Application
10.2.6.5.3 United Kingdom Cell And Gene Therapy Market by End- Users
10.2.6.6 Rest of Europe Cell And Gene Therapy Market
10.2.6.6.1 Rest of Europe Cell And Gene Therapy Market by Type
10.2.6.6.2 Rest of Europe Cell And Gene Therapy Market by Application
10.2.6.6.3 Rest of Europe Cell And Gene Therapy Market by End- Users
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cell And Gene Therapy Market Overview
10.3.2 Asia-Pacific Cell And Gene Therapy Market Forecasts and Analysis
10.3.3 Asia-Pacific Cell And Gene Therapy Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Cell And Gene Therapy Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Cell And Gene Therapy Market Forecasts and Analysis - By End- Users
10.3.6 Asia-Pacific Cell And Gene Therapy Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cell And Gene Therapy Market
10.3.6.1.1 Australia Cell And Gene Therapy Market by Type
10.3.6.1.2 Australia Cell And Gene Therapy Market by Application
10.3.6.1.3 Australia Cell And Gene Therapy Market by End- Users
10.3.6.2 China Cell And Gene Therapy Market
10.3.6.2.1 China Cell And Gene Therapy Market by Type
10.3.6.2.2 China Cell And Gene Therapy Market by Application
10.3.6.2.3 China Cell And Gene Therapy Market by End- Users
10.3.6.3 India Cell And Gene Therapy Market
10.3.6.3.1 India Cell And Gene Therapy Market by Type
10.3.6.3.2 India Cell And Gene Therapy Market by Application
10.3.6.3.3 India Cell And Gene Therapy Market by End- Users
10.3.6.4 Japan Cell And Gene Therapy Market
10.3.6.4.1 Japan Cell And Gene Therapy Market by Type
10.3.6.4.2 Japan Cell And Gene Therapy Market by Application
10.3.6.4.3 Japan Cell And Gene Therapy Market by End- Users
10.3.6.5 South Korea Cell And Gene Therapy Market
10.3.6.5.1 South Korea Cell And Gene Therapy Market by Type
10.3.6.5.2 South Korea Cell And Gene Therapy Market by Application
10.3.6.5.3 South Korea Cell And Gene Therapy Market by End- Users
10.3.6.6 Rest of Asia-Pacific Cell And Gene Therapy Market
10.3.6.6.1 Rest of Asia-Pacific Cell And Gene Therapy Market by Type
10.3.6.6.2 Rest of Asia-Pacific Cell And Gene Therapy Market by Application
10.3.6.6.3 Rest of Asia-Pacific Cell And Gene Therapy Market by End- Users
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cell And Gene Therapy Market Overview
10.4.2 Middle East and Africa Cell And Gene Therapy Market Forecasts and Analysis
10.4.3 Middle East and Africa Cell And Gene Therapy Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Cell And Gene Therapy Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Cell And Gene Therapy Market Forecasts and Analysis - By End- Users
10.4.6 Middle East and Africa Cell And Gene Therapy Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cell And Gene Therapy Market
10.4.6.1.1 South Africa Cell And Gene Therapy Market by Type
10.4.6.1.2 South Africa Cell And Gene Therapy Market by Application
10.4.6.1.3 South Africa Cell And Gene Therapy Market by End- Users
10.4.6.2 Saudi Arabia Cell And Gene Therapy Market
10.4.6.2.1 Saudi Arabia Cell And Gene Therapy Market by Type
10.4.6.2.2 Saudi Arabia Cell And Gene Therapy Market by Application
10.4.6.2.3 Saudi Arabia Cell And Gene Therapy Market by End- Users
10.4.6.3 U.A.E Cell And Gene Therapy Market
10.4.6.3.1 U.A.E Cell And Gene Therapy Market by Type
10.4.6.3.2 U.A.E Cell And Gene Therapy Market by Application
10.4.6.3.3 U.A.E Cell And Gene Therapy Market by End- Users
10.4.6.4 Rest of Middle East and Africa Cell And Gene Therapy Market
10.4.6.4.1 Rest of Middle East and Africa Cell And Gene Therapy Market by Type
10.4.6.4.2 Rest of Middle East and Africa Cell And Gene Therapy Market by Application
10.4.6.4.3 Rest of Middle East and Africa Cell And Gene Therapy Market by End- Users
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cell And Gene Therapy Market Overview
10.5.2 South and Central America Cell And Gene Therapy Market Forecasts and Analysis
10.5.3 South and Central America Cell And Gene Therapy Market Forecasts and Analysis - By Type
10.5.4 South and Central America Cell And Gene Therapy Market Forecasts and Analysis - By Application
10.5.5 South and Central America Cell And Gene Therapy Market Forecasts and Analysis - By End- Users
10.5.6 South and Central America Cell And Gene Therapy Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cell And Gene Therapy Market
10.5.6.1.1 Brazil Cell And Gene Therapy Market by Type
10.5.6.1.2 Brazil Cell And Gene Therapy Market by Application
10.5.6.1.3 Brazil Cell And Gene Therapy Market by End- Users
10.5.6.2 Argentina Cell And Gene Therapy Market
10.5.6.2.1 Argentina Cell And Gene Therapy Market by Type
10.5.6.2.2 Argentina Cell And Gene Therapy Market by Application
10.5.6.2.3 Argentina Cell And Gene Therapy Market by End- Users
10.5.6.3 Rest of South and Central America Cell And Gene Therapy Market
10.5.6.3.1 Rest of South and Central America Cell And Gene Therapy Market by Type
10.5.6.3.2 Rest of South and Central America Cell And Gene Therapy Market by Application
10.5.6.3.3 Rest of South and Central America Cell And Gene Therapy Market by End- Users

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. CELL AND GENE THERAPY MARKET, KEY COMPANY PROFILES
12.1. GILEAD SCIENCES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BRISTOL-MYERS SQUIBB
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SPARK THERAPEUTICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AMGEN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIOGEN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. DENDREON
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VERICEL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Gilead Sciences
2. Bristol-Myers Squibb
3. Novartis AG
4. Spark Therapeutics
5. Amgen
6. Merck
7. Biogen
8. Pfizer
9. Dendreon
10. Vericel
TIPRE00020854
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.